Lymph nodes (LNs) are strategically situated throughout the body at junctures of the blood vascular and lymphatic systems to direct immune responses against antigens draining from peripheral tissues. The current paradigm describes LN development as a programmed process that is governed through the interaction between mesenchymal lymphoid tissue organizer (LTo) cells and hematopoietic lymphoid tissue inducer (LTi) cells. Using celltype-specific ablation of key molecules involved in lymphoid organogenesis, we found that initiation of LN development is dependent on LTi-cell-mediated activation of lymphatic endothelial cells (LECs) and that engagement of mesenchymal stromal cells is a succeeding event. LEC activation was mediated mainly by signaling through receptor activator of NF-kB (RANK) and the non-canonical NF-kB pathway and was steered by sphingosine-1-phosphate-receptor-dependent retention of LTi cells in the LN anlage. Finally, the finding that pharmacologically enforced interaction between LTi cells and LECs promotes ectopic LN formation underscores the central LTo function of LECs.
In Brief
Lymph node (LN) formation is thought to rely mainly on interactions between mesenchymal lymphoid tissue organizer cells and lymphoid tissue inducer cells. Onder et al. now show that LN formation is governed by RANK-dependent activation of lymphatic endothelial cells that control retention of lymphoid tissue inducer cells in embryonic LN anlagen.
SUMMARY
Lymph nodes (LNs) are strategically situated throughout the body at junctures of the blood vascular and lymphatic systems to direct immune responses against antigens draining from peripheral tissues. The current paradigm describes LN development as a programmed process that is governed through the interaction between mesenchymal lymphoid tissue organizer (LTo) cells and hematopoietic lymphoid tissue inducer (LTi) cells. Using celltype-specific ablation of key molecules involved in lymphoid organogenesis, we found that initiation of LN development is dependent on LTi-cell-mediated activation of lymphatic endothelial cells (LECs) and that engagement of mesenchymal stromal cells is a succeeding event. LEC activation was mediated mainly by signaling through receptor activator of NF-kB (RANK) and the non-canonical NF-kB pathway and was steered by sphingosine-1-phosphate-receptor-dependent retention of LTi cells in the LN anlage. Finally, the finding that pharmacologically enforced interaction between LTi cells and LECs promotes ectopic LN formation underscores the central LTo function of LECs.
INTRODUCTION
Lymph nodes (LNs) are immunological junctions positioned throughout the mammalian body at sites where soluble and cell-associated antigens drain from peripheral tissues via afferent lymph vessels (Junt et al., 2008) . Tissue-derived lymph fluid is drained through LNs, where it passes the subcapsular sinus, which is lined by a monolayer of lymphatic endothelial cells (LECs) and adhering resident macrophages (Gaya et al., 2015; Junt et al., 2007) . At the same time, these sinuses are transit zones for antigen-carrying dendritic cells (Fö rster et al., 2012; Platt and Randolph, 2013) . The LEC microstructure of LNs consists of sinusoidal extensions that begin at the peripheral afferent lymph vessels and are further distributed below the capsule surrounding T and B cell areas and thereby foster antigen distribution and lymphocyte migration (Fö rster et al., 2012) . Hence, LNs allow for retention and appropriate distribution of antigenic material through lymphatic vessels for activation of innate and adaptive immune cells.
The importance of LNs for protection against viral infection has been demonstrated with the use of alymphoplastic mice that exhibit a mutation in the NF-kB-inducing kinase (Karrer et al., 1997; Macpherson and Uhr, 2003) . Likewise, transplant recipients with impaired LN formation are not able to mount immune responses that efficiently reject tissue grafts (Lakkis et al., 2000; Zhou et al., 2003) . Moreover, defects in LN organogenesis in humans through genetic aberrations in the canonical NF-kB pathway lead to increased susceptibility to infection despite normal generation of hematopoietic cells (Mooster et al., 2015) , emphasizing the importance of these lymphoid organs to establishing and maintaining regional immunity.
LNs develop in the sterile environment of the fetus at particular lymphatic drainage regions (Eberl, 2007) . It appears that the formation of LNs in mice kept under specific-pathogen-free conditions is fairly constant, leading to the formation of 22 LNs in distinct locations (Van den Broeck et al., 2006) . In contrast, the abundance of LNs in humans is highly variable (Friedman et al., 1999) , and proper LNs can appear close to or even inside glandular human tissues such as the breast, which is usually devoid of LNs (Troupis et al., 2012) , suggesting that LN formation is an adaptive process. Currently, LN organogenesis is seen as a programmed sequence of events that involves the interaction between mesenchymal stromal cells and embryonic type 3 innate lymphoid cells (ILC3s) (Eberl, 2007; Randall et al., 2008; Spits et al., 2013; van de Pavert and Mebius, 2010) . The presence of these fetal-liver-derived, RORgT-expressing lymphoid tissue inducer (LTi) cells is essential for the development of (legend continued on next page)
LNs Yoshida et al., 1999) . Results from mice globally deficient in chemokine (C-X-C motif) ligand 13 (CXCL13) and its receptor C-X-C chemokine receptor type 5 (CXCR5) have led to the conclusion that LTi cells are attracted to mesenchymal lymphoid tissue organizer (LTo) cells via CXCR5 (Finke et al., 2002) . In a second step, inductive LTi cell clusters in which lymphotoxin (LT)a 1 b 2 from LTi cells ligates the LTb receptor (LTbR) on LTo cells are formed. Indeed, LTbR or other tumor necrosis factor receptor (TNFR) family members, such as receptor activator in NF-kB (RANK), that signal via the non-canonical NF-kB pathway are critical for the formation of lymphoid organs (Dougall et al., 1999; Fu and Chaplin, 1999; F€ utterer et al., 1998) . Stimulation of mesenchymal LTo cells through these pathways is currently seen as the main driver of further production of the ligands of C-C chemokine receptor type 7 (CCR7) and CXCR5, leading to the attraction of T and B cells to the LN anlage (Ohl et al., 2003; Randall et al., 2008) . Although molecular details of the interaction between mesenchymal LTo and LTi cells have been studied in vivo (Bé né zech et al., 2010) , the sequence of events at the inductive sites of LN formation has remained unclear. It has been suggested that mesenchymal LTo cells originate from migrating adipose stromal cells that populate the LN anlage (Brendolan and Caamañ o, 2012) , a view that is supported by the finding that pre-adipocytes can be recruited into adult LNs in a LTbR-dependent manner (Bé né zech et al., 2012) . A second scenario suggests that the nerve-derived metabolite retinoic acid (RA) triggers CXCL13 production in early LN anlagen and hence governs activation of mesenchymal LTo cells ). However, genetic ablation of Ltbr expression in CCL19-expressing mesenchymal LTo cells in the LN anlage revealed that this step is not essential for the development of LNs . Moreover, activation of endothelial cells (ECs) via LTbR in LN anlagen has been shown to be involved in LN organogenesis . Interestingly, Ltbr-deficient CCL19-expressing mesenchymal LTo cells in the anlagen of Peyer's patches fail to fully support formation of these intestinal lymphoid organs . Thus, it appears that distinct processes operate during the generation of LNs and other lymphoid organs with different degrees of involvement of mesenchymal LTo cells.
To molecularly decipher the role of mesenchymal stromal cells and other potential organizer cells during LN development, we ablated Ltbr in embryonic CXCL13-expressing mesenchymal LTo cells and found that this cellular pathway was dispensable for LN formation. In stark contrast, ablation of both Ltbr and non-canonical NF-kB signaling in ECs almost completely blocked LTi cell aggregation in LN anlagen and, as a consequence, LN formation. Forced retention of LTi cells in LN anlagen through application of the sphingosine-1-phosphate receptor inhibitor fingolimod (FTY720) and targeted ablation of Rank expression in LECs revealed that LECs forming the early LN anlage regulate LTi cell migration and retention. Importantly, activation of mesenchymal LTo cells in the LN anlage occurred only subsequently to productive interaction between LTi cells and LECs. Together, these results indicate that LECs in the early embryonic LN anlage act as endothelial LTo cells and reveal a distinct hierarchy in the contribution of different stromal cell populations to the process of LN organogenesis.
RESULTS

Role of CXCL13-Expressing Mesenchymal Stromal Cells in LN Development
To follow the development of CXCL13-producing mesenchymal stromal cells during lymphoid organ development, we generated Cxcl13-Cre/Tdtomato mice and crossed this strain with enhanced yellow fluorescent protein (EYFP)-transgenic reporter mice (Cxcl13-Cre/Tdtomato R26R-EYFP, abbreviated as Cxcl13-EYFP) (Figures S1A-S1F; Srinivas et al., 2001) . Because the formation of individual LNs during embryogenesis follows a distinct pattern (Rennert et al., 1998) , we first determined the prevalence and location of transgene-expressing cells in developing LNs of Cxcl13-EYFP mice. As shown in Figure 1A , the presence of CXCL13-expressing perivascular fibroblasts could be detected at embryonic day (E) 14 in the inguinal (i)LN anlage concomitant with the aggregation of few CD4 + LTi cells (Figure 1A) . Initial LTi cell accumulation has been shown to be followed by a LTbR-dependent activation phase (Rennert et al., 1996) with increasing density of activated mesenchymal stromal cells between E14 and E17 (Bé né zech et al., 2010). As expected, we found an expansion of Cxcl13-Cre-tagged fibroblasts and CD4 + RORgt + LTi cells forming the growing iLN at the branching point of the subepigastric blood vessels within the inguinal fat pad ( Figures 1B and 1C ). These data indicate that the novel Cxcl13-Cre/Tdtomato model facilitates tracking of mesenchymal stromal cell differentiation in adult LNs and permits genetic manipulation of mesenchymal LTo cells in the early LN anlage.
Next, we assessed whether genetic ablation of Ltbr expression in CXCL13-producing mesenchymal stromal cells affects LN formation. All LNs, including the iLN ( Figure 1D) with n = 5-8 mice per group ± SEM).
(G) Presence of peripheral LNs in adult mice of the indicated genotypes. Peripheral LN index includes superficial cervical, brachial, axillary, para-aortic, inguinal, and popliteal LNs (all examined LNs present, total = 12). Statistical analysis was performed by one-way-ANOVA (including a Bonferroni multiple-comparison test), pooled data from two independent experiments. Microscopy and flow cytometry data are representative for two or more independent experiments (n R 4 per group). See also Figure S1 .
maturation of fibroblastic stromal cells with loss of high podoplanin (PDPN) expression ( Figure 1F ). These findings are compatible with the results obtained with targeted Ltbr ablation in CCL19-expressing cells, which had suggested that triggering of the LTbR pathway in mesenchymal LTo cell is not critical for peripheral LN formation ( Figure 1G ; Chai et al., 2013) . Interestingly, organogenesis of Peyer's patches (PPs) was dependent on Ltbr expression in CCL19- and in CXCL13-expressing mesenchymal LTo cells ( Figure S1G ). Likewise, formation of the splenic white pulp ( Figure S1H ) and optimal accumulation of hematopoietic cells in the spleen ( Figure S1I ) required Ltbr-competent CXCL13-expressing cells, indicating that mesenchymal LTo cells critically contribute to the organogenesis of PPs and the splenic white pulp, whereas steering of LN formation is taken over by other organizer cells. Finally, to assess whether mesenchymal LTo cells in LNs interact with endothelial LTo cells in a synergistic fashion, we abrogated Ltbr expression both in VE-cadherin-expressing blood vascular and lymphatic ECs (Cdh5-Cre transgenic mice as described in Onder et al., 2013) and in CXCL13-expressing mesenchymal LTo cells. Development of LNs was not affected beyond the 30% reduction achieved by Ltbr ablation in the EC compartment (Figures 1G, 2A, and 2B; Onder et al., 2013) , confirming that mesenchymal LTo cell activation via this pathway is not the primary driver of LN organogenesis.
Non-canonical NF-kB Signaling in ECs Controls LN Development
On the basis of the findings that global ablation of Ltbr expression results in complete abrogation of LN organogenesis (F€ utterer et al., 1998) and that EC-specific ablation of Ltbr expression impairs LN formation and functionality , we hypothesized that the main signals facilitating the initiation of LN formation are provided by an endothelial LTo cell. Because the main morphogenic signals that drive LN organogenesis, i.e., LTbR or RANK, are integrated via the non-canonical NF-kB pathway (De Trez and Ware, 2008) , we employed a recently developed mouse model of conditional deficiency in the NF-kB-inducing kinase (NIK) Onder et al., 2015) . Indeed, crossing of Cdh5-Cre mice with Nik fl/fl mice resulted in further impairment of peripheral LN formation in comparison with EC-specific ablation of the Ltbr ( Cdh5-Cre Nik fl/fl mice were substantially smaller than iLNs found in control mice ( Figure 2C ) and displayed significantly reduced cellularity ( Figure 2D ). These data indicate that non-canonical NF-kB signaling in ECs is the dominant pathway for the development of peripheral LNs and strongly suggest that LTbR signals in ECs are integrated through both the non-canonical and the canonical NF-kB pathway during this process.
To dissect the mechanisms that determine the failure of LN formation in 
Enforced LTi Cell Retention Promotes Generation of Ectopic LNs
Lymphocyte accumulation in adult LNs is regulated mainly through chemokine-dependent influx and control of sphingosine-1-phosphate receptor-dependent efflux (Cyster and Schwab, 2012) . Hence, we considered it likely that the balance between these processes determines the overall retention of LTi cells in the LN anlage. High-resolution microscopic analysis revealed that LTi cells were lined up in lymph vessels leading to the E14 iLN anlage and closely attached to CCL21-decorated LECs ( Figure 4A ). At E17, CCL21 expression was restricted to the main lymph vessels that lead to and enwrap the LN anlage ( Figures 4B and S3A ). Ccl19 promoter activity became detectable only after E14 ( Figure S3B ) and was limited to cells located in the center of the anlage that did not express the LEC marker lymphatic vessel endothelial hyaluronan receptor 1 (LYVE1) (Figures 4C and S3C) . These data suggest that early LTi cell attraction to the LN anlage occurs mainly via afferent lymph vessels and that CCL21-expressing LECs guide the cells to major lymph vessel junctions. Treatment with the immunosuppressive drug FTY720 (fingolimod) was shown to modulate homing and emigration of lymphocytes from adult lymphoid organs by acting on sphingosine-1-phosphate (S1P) receptors (Brinkmann et al., 2002; Mandala et al., 2002) . The increase of both S1pr1 ( Figure 4D ) and S1pr2 ( Figure 4E ) mRNA expression in the embryonic inguinal fat pad stimulated us to treat pregnant control dams with FTY720 at E14 and E16. This treatment was associated with increased LTi cell retention ( Figure 4F ) and substantial upregulation of Ccl21a and Ccl21b mRNA expression in inguinal fat pads at E17 ( Figure 4G ). Moreover, we observed accumulation of LTi cells and enhanced VCAM1 expression at a dorsal branching point of the subepigastric vessels at E18 (Figures 4H and S3D) . Overall, we found that 40% of the offspring of FTY720-treated dams had formed ectopic LNs at this particular location (Figure 4I) . Further histological analysis revealed that ectopic LNs possess a regular FRC network and exhibit the typical zonal organization with paracortical T cell zones and cortical B cell follicles ( Figure S3E ). Moreover, paracortical high endothelial venule (HEV) networks had developed ( Figure S3F ), LYVE1 + subcapsular sinuses had been formed ( Figure S3G ), and functional ER-TR7 + conduits were present that were able to drain lymph-borne small molecular compounds through the LN parenchyma (Figure S3H) . Further functional assessments revealed that ectopic LNs support the generation of antiviral CD8 + T cells (not shown). These gain-of-function experiments reveal that LTi cell retention at branching points of major lymph vessels is the major driver for the formation of functional LNs. Error bars show mean ± SEM, Student's t test; microscopy and flow cytometry data are representative for two or more independent experiments (n R 4 per group). See also Figure S2 and Movie S1. (C) A comparable region as boxed area in (B) was analyzed in E17 Ccl19-EYFP embryonic iLN anlagen for Ccl19-Cre-mediated transgene expression (EYFP), CCL21, and reconstructed LYVE1 + lymphatic vessel (yellow) (scale bar, 10 mm).
(D and E) E14 and E17 inguinal fat pads from C57BL/6 embryos were isolated and gene expression levels of (D) S1pr1 and (E) S1pr2 were determined by quantitative RT-PCR (n = 8 per group, from 2 independent experiments).
(F) Presence of CD45 + CD4 + LTi cells in E17 inguinal fat pads of C57BL/6 embryo from dams treated with FTY720 or vehicle at E14 and E16 as determined by flow cytometry (n = 7 per group, from 2 independent experiments).
(legend continued on next page)
Interaction between LTi Cells and Lymphatic ECs Initiates LN Organogenesis
The initial LTi cell influx via afferent lymphatic vessels and their aggregation at the junction of larger lymph vessels suggested that their interaction with LECs could be crucial for the activation of the LN anlage. To address this question, we employed LEC-directed Cre recombinase expression in Lyve1-Cre mice (Pham et al., 2010) and in Prox1-CreERT2 mice (Bazigou et al., 2011) . As shown in Figure 5A , Lyve1-Cre-mediated EYFP expression could be detected in LYVE1 + lymphatic vessels that connected to the primordial iLN anlage at E14 and had ensheathed the anlage by E17 ( Figure 5B ). Moreover, transgene-targeted LECs were found in close contact with CD4 + LTi cells both at E14 and E17 ( Figures 5A and 5B , arrowheads, and Figure S4A ). Conditional ablation of Ltbr and Nik expression in Lyve1-Cre-expressing cells precipitated a loss of peripheral LNs in approximately 70% of the mice, whereas the loss of Rank expression significantly diminished LN formation in all (G) Quantitative RT-PCR analysis of Ccl21a and Ccl21b mRNA expression inguinal fat pads of E17 C57BL/6 embryos from FTY720-treated dams (n = 7-10 per group, from 2 independent experiments).
(H) Whole-mount staining of ectopic LN anlagen at E16 (after FTY720 treatment on E14, left image) and E18 (after FTY720 treatment on E14 and E16, right image) were stained with the indicated antibodies (scale bars, 20 mm).
(I) Micrographs of iLNs and ectopic LNs in 6-week-old C57BL/6 mice, which were treated during E14 and 16 with FTY720. Arrowhead indicates ectopic LN on the dorsal side of the inguinal fat pad. Numbers indicate presence of iLNs and ectopic LNs in fat pads in a total of 7 and 11 of control versus FTY720-treated mice (pooled data from three experiments). Error bars show mean ± SEM, Student's t test; microscopy data are representative for 2 or more independent experiments (n R 3 per group). See also Figure S3 . Figure 5D ) suggested that these pathways contribute to LEC activation during the early phase of LN organogenesis. Because the Lyve1-Cre transgene exhibits recombinase activity in a fraction of hematopoietic cells (Pham et al., 2010) , we utilized LEC-specific Cre recombinase expression in Prox1-CreERT2 mice to conditionally ablate Rank in the embryonic iLN anlage. Indeed, the lack of Rank expression in LECs substantially reduced LTi cell retention and expression of ICAM1 and VCAM1 in the inguinal fat pad ( Figures 5D, 5E Figure 5D ), a condition that corresponded to regular LTi cell distribution and high expression of ICAM1 and VCAM1 in the anlage (example 1 in Figures 5F and 5G ). It appears that LN formation was substantially affected below a threshold of 600 LTi cells per fat pad ( Figure 5D ), which was associated with low or absent expression of ICAM1 and VCAM1 (examples 2 and 3 in Figure 5G) . In summary, these data indicate that initiation of LN organogenesis is dependent on the retention of LTi cells in the LN anlage and that LEC-LTi cell interaction is mainly steered via RANK signals in LECs.
Blood Vascular EC Activation in the LN Anlage
Pharmacological inhibition of LTi cell egress from LN anlagen with FTY720 led to the formation of ectopic LNs in control mice ( Figure 4I ) and, hence, an increase in the peripheral LN index ( Figure 6A Figure 6C ) and altered branching of the subepigastric artery at E18 (asterisk in Figure 6C ). These data suggest that growth and differentiation of blood ECs (BECs) in the developing LN anlage is stimulated through the LTbR and the non-canonical NF-kB pathway only after E16. Indeed, activation of the blood vasculature with enhanced expression of ICAM1 or mucosal addressin cell adhesion molecule 1 (MadCAM1) in the inguinal LN anlage was not detectable at E14 (Figures 6D and 6E ), whereas elevated expression of these adhesion molecules was mainly found in BECs of the subepigastric vein at E16 (Figures 6F and 6G) . At E18, all BECs including those of arteries and postcapillary veins showed elevated ICAM1 expression ( Figure S5A ). Importantly, activation of BECs was abrogated in Cdh5-Cre Ltbr fl/fl Nik fl/fl anlagen (Figures 6H and S5B) . Likewise, expression of high levels of Mad-CAM1 by BECs in the inguinal LN anlage was dependent on EC-specific LTbR and NIK signals ( Figure 6I ). These data indicate that BEC activation and angiogenic activity with formation of the LN vasculature occurs after the initial LEC-mediated retention of LTi cells in the LN anlage, i.e., after E16. Moreover, the most likely scenario for the concluding steps in LN organogenesis includes the concomitant development of the inguinal LN vasculature and full activation of chemokine-producing mesenchymal stromal cells after E16 which facilitate accelerated recruitment of LTi cells via the blood vasculature and final preparation of the LN infrastructure.
DISCUSSION
The prevailing paradigm describing LN organogenesis is based on a two-cell-type interaction scheme, i.e., LTi-cell-mediated stimulation of mesenchymal LTo cells (Mebius, 2003; Randall et al., 2008) . The current study provides an alternative scenario for the hierarchically organized processes that govern LN formation. We found that balancing of LTi cell recirculation and retention by lymphatic endothelial LTo cells is the first-order parameter in the decision-making process that leads to the initial activation of the LN anlage. This finding implies that fetal liverderived LTi cells circulate through the vascular system, exit into the developing tissues, and recirculate through the lymphatic system to accumulate in lymphatic junctures or to continue their journey. Such undirected ''swarm'' behavior is conserved in the adult immune system and can be observed in the migration pattern of naive T lymphocytes which migrate randomly through tissues and recirculate via the lymphatic system (Cose et al., 2006; Lewis et al., 2008; Luettig et al., 2001) . Importantly, neonatal tissues are particularly permissive to increased migration of naive T cells (Alferink et al., 1998) , supporting the notion that LTi cells in the embryo also find their way into the early LN anlage via this route. Our study shows that the threshold for the initiation of LN organogenesis can be lowered by pharmacologically increasing retention of LTi cells in major lymphatic junctions or elevated by genetic ablation of particular activation signals in LECs. Under these premises, LN formation will be initiated only if sufficient LTi cells appear within a particular time window in a potential LN anlage. It remains possible that signals such as retinoic acid derived from nerve endings in the LN anlage ) impinge on LTo cell activation and/or LTi cell migration patterns to foster conditioning of the LN anlage.
The results from this and our previous study are not compatible with the view that mesenchymal LTo cells are the primary participants in the initiation process of LN formation. Although mesenchymal stromal cell activation in the LN anlage is a potent mechanism for the generation of chemokines and additional activation factors, we consider it likely that the rapid expansion of the blood vascular system in the growing LN is driven to a large extent by vascular growth factors that can be provided by activated mesenchymal stromal cells (Armulik et al., 2011) . Future studies are required to dissect the post-initiation processes of LN organogenesis and to clarify the role of the potential interaction between mesenchymal LTo cells and the blood vascular endothelium. The current reductionist two-cell scenario of LN organogenesis has been established on the basis of comparing phenotypes of mice globally deficient in various morphogenic factors and pathways (Remouchamps et al., 2011; van de Pavert and Mebius, 2010) . A major limitation of this approach is the lack of resolution in terms of the identity of involved cell types and the interdependence of different molecular players. For example, the presence of LTi cells in Prox1-deficient embryonic LN anlagen has been interpreted as evidence that LNs can form in the absence of LECs ). However, this interpretation could be misperceived given that global ablation of the essential transcription factor PROX1 leads to embryonic lethality. The analysis provided here employed cell-type-specific genetic ablation of factors contributing to the formation of lymphoid organs and revealed that LN organogenesis involves at least two different classes of LTo cells. Signaling via the master regulator of lymphoid organogenesis, i.e., LTbR, in both CCL19-and CXCL13-expressing mesenchymal LTo cells appears not to be critical for the decision of whether LN formation is initiated. In contrast, development of PPs and splenic white pulp required Ltbr expression in mesenchymal LTo cells. The reduction of PP numbers in Cxcl13-Cre Ltbr fl/fl mice by 60% suggests that mesenchymal LTo cells in these organs not only receive signals via the LTbR, but integrate additional stimulation via the TNFR1, which has been shown to support PP organogenesis (Neumann et al., 1996; Pasparakis et al., 1997) . Interestingly, signals via the TNFR1 are mainly transmitted through the canonical NF-kB pathway (Hayden and Ghosh, 2014) , whereas the LTbR activates mainly the non-canonical branch of NF-kB signaling (Remouchamps et al., 2011) . Nevertheless, there is substantial crosstalk between the two pathways, as demonstrated, for example, by the NIK-dependent activation of the inhibitor of kB (IkB) alpha in response to LTbR stimulation (Matsushima et al., 2001) . Hence, it is likely that ECs targeted by the Cdh5-Cre transgene support LN formation via both the canonical and non-canonical NF-kB pathway following LTbR ligation. Our finding that RANK is the dominant but not sole factor that governs LTi cell-LEC interaction further illustrates that LN organogenesis is initiated only when a certain threshold of extra-and intracellular signals has been reached. Clearly, the initial signal integration through different surface molecules and intracellular pathways occurs in LECs and a failure to reach the threshold abrogates the subsequent steps of LN organogenesis including BEC and mesenchymal stromal cell activation. It remains to be determined to what extent RANK-mediated signaling in BECs (Mueller and Hess, 2012) or mesenchymal stromal cells contributes to the processes that lead to LN organogenesis. Moreover, cell-type-specific ablation of further morphogenic factors in mesenchymal and/or endothelial LTo cells will clarify when and where additional molecular pathways are involved in the formation of lymphoid organs.
In summary, we suggest a substantial revision of the LN organogenesis paradigm with inclusion of lymphatic endothelial LTo cells that determine the location and drive the initial steps of LN formation. Importantly, the processes that operate during the development of lymphoid organs in the sterile environment of the embryo are recapitulated in the course of chronic inflammatory diseases that lead to the formation of tertiary lymphoid organs (Buckley et al., 2015; Drayton et al., 2006; Ruddle, 2014) . Hence, the results provided in this study advance the knowledge of the basic processes that determine the quality and intensity of immune reactivity in secondary and tertiary lymphoid organs and can therefore guide the development of approaches that improve and/or equilibrate immune function.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Animal Experiments
All animals were kept under conventional conditions in individually ventilated cages and experiments were performed with 6-8 week old mice (4 or more mice per group). For embryo staging, mice of indicated strains were used at the age of 6-10 weeks. As control (Ctrl) animals, co-housed and Cre-negative littermate mice (6-8 weeks of age) or embryos (E12-E18) have been used in all experiments. Experiments were performed in accordance with Swiss federal and cantonal guidelines (Tierschutzgesetz) under the permissions SG16/07, SG09/14 and SG11/15 granted by the Veterinary Office of the Canton of St. Gallen and in conformity to the animal bioethics legislation approved by and according to national guidelines of the CREMEAS (Comité Ré gional d'Ethique en Matiè re d'Expé rimentation Animale de Strasbourg), permit number AL/03/12/05/12.
Mouse Model Generation BAC-transgenic C57BL/6N-Tg(Cxcl13-Cre/Tdtomato)719Biat (Cxcl13-Cre/Tdtomato) mice were generated using BAC RP23-57A17 (Invitrogen), transgene integration was achieved using Red/ET recombination technologies (Gene bridges) according to the manufacturer's protocol and as previously described (Sparwasser et al., 2004) . Proper transgene integration was assessed by Southern blot analysis and mice were genotyped using the following primers: forward 5 0 -TCTCTGCCCAGAGTCATCCT-3 0 , reverse 5 0 -ATGCTCCTGTCTGTGTGCAG-3 0 .
METHOD DETAILS Embryology
For embryo staging, mice of indicated strains were used at the age of 6-10 weeks. Female mice were stimulated overnight to induce timed ovulation and mated with appropriate males in fresh cages. On the following day, females were checked for vaginal plugs and positive individuals were considered for E0.5. For histological analysis, embryos were fixed in 4% paraformaldehyde (MerckMillipore) or directly dissected to isolate inguinal fat pads and LN anlagen for flow cytometric or gene expression analysis. Embryos were dissected with fine surgical instruments under the stereomicroscope. For isolation of inguinal fat pads and LN anlagen, dorsal, and abdominal skin was removed and fat pads were made accessible for isolation with fine forceps. For whole mount histology, skin covering the inguinal fat pad was removed together with the fat pad and directly used for immunohistochemical staining. iLN anlagen were identified by the bifurcation of major blood vessels in the inguinal fat pad.
Tamoxifen Treatment 4-Hydroxytamoxifen was administered to pregnant mice at E11 and tamoxifen at E12 at a concentration of 50 mg/kg body weight by oral gavage.
FTY720
Treatment FTY720 (fingolimod hydrochloride, Sigma-Aldrich) or vehicle was given at a concentration of 1 mg/kg body weight and injected twice intraperitoneally in pregnant females at E14 and E16. For visualization of LNs and PPs in adult mice, 0.1 mL 1% Chicago sky blue (Sigma Aldrich) was injected intraperitoneally and mice were analyzed one week after injection.
Injection of Soluble Tracers and Antibodies
For conduit analysis, adult mice were injected subcutaneously with FITC-dextran (molecular weight 40 kDa, Molecular Probes) and LNs were harvested 15 min after injection . HEV networks were visualized by injection of 12 mg MECA79-Cy3 antibody intravenously into adult mice as described previously (Kumar et al., 2010) . Ten minutes after injection, mice were euthanized and LNs were isolated and fixed in 4% paraformaldehyde for 2 hr. Prior to imaging, whole LNs were cleared using FocusClear (CellExplorer) agent.
Preparation of Stromal Cells from LN Anlagen and LNs
LNs and inguinal fat pads were cut into small pieces and collected in RPMI 1640 medium containing 2% FCS, 20 mM HEPES (all from Lonza), 0.5 mg/ml Collagenase P, 0.5 mg/ml Dispase (Roche) and 25 mg/ml DNaseI (Applichem). Dissociated tissue was incubated at 37 C for 30 min (inguinal anlagen for 10 min), with resuspension and collection of supernatant every 10 min. After enzymatic digestion, cell suspensions were filtered and washed with PBS containing 0.5% FCS and 10 mM EDTA. For adult LNs, stromal cells were enriched by depleting CD45 + hematopoietic cells and TER119 + erythrocytes using MACS microbeads and passing over magnetic columns (Miltenyi, Germany) as described previously . Cell suspensions were directly used for staining with antibodies.
Flow Cytometry
Cell suspensions of adult LNs and embryonic tissue were incubated for 20 min at 4 C in PBS containing 1% FCS and 10 mM EDTA with the following antibodies: anti-CD45, anti-Ter-119/Erytroid (TER119), anti-PDPN (all from Biolegend), anti-CD31, anti-ICAM1, anti-VCAM1, anti-B220, anti-CD19 and anti-CD4 (all from eBioscience). Secondary antibodies and streptavidin have been used to detect unlabeled primary antibodies or biotinylated antibodies and were coupled with Alexa Fluor or Dylight fluorochromes (from Jackson Immunotools). 7-amino-actinomycin D (7AAD; Calbiochem) was used to discriminate dead cells in flow cytometric analyses. Cells were acquired with a FACS Canto II or LSR Fortessa (BD Biosciences) and analyzed using FACS Diva 8 (BD Biosciences) and FlowJo (Version 7 and 10) software (Tree Star).
Immunohistochemistry and Microscopy
Organs and anlagen were fixed overnight at 4 C or for 2 hr at room temperature in freshly prepared 4% paraformaldehyde (Merck Millipore) under agitation. Organs of adult mice were embedded and orientated in 4% low melting agarose (Invitrogen) in PBS and serially sectioned with a vibratome (Leica VT-1200). 30-40 mm thick sections and whole mount tissue were blocked in PBS containing 10% FCS, 1 mg/ml anti-Fcg receptor (BD Biosciences) and 0.1% Triton X-100 (Sigma). Tissues were incubated overnight at 4 C with the following antibodies: anti-CD31, anti-LYVE1, anti-RORgt, anti-ICAM1, anti-VCAM1, anti-PDPN, anti-MadCAM1 (all from eBioscience), anti-CD4, anti-B220 (all from Biolegend), anti-SMA (Sigma), anti-EYFP (Clontech), anti-ERTR7 (Abcam) or anti-CCL21 (RnD Systems). Unconjugated antibodies were detected with the following secondary antibodies: Dylight649-conjugated anti-ratIgG, Alexa488-conjugated anti-rabbit-IgG, Dylight549-conjugated anti-syrian hamster-IgG and Dylight549-conjugated Streptavidin (all purchased from Jackson Immunotools). Microscopy was performed using a confocal microscope (LSM-710, Carl Zeiss). Microscopy data were recorded and processed with ZEN 2010 software (Carl Zeiss). Imaris Versions 7 and 8 (Bitplane) were used for rendering, masking, reconstruction, and histo-morphometric and volumetric analysis of confocal z stacks. LN anlagen were imaged as mosaic tile-scans with 10% overlap between neighboring z stacks, confocal z stacks were stitched in ZEN 2010 software and 3-D reconstructed and processed in Imaris.
Quantitative Real-Time PCR Total cellular RNA was extracted from homogenized tissues using TRIZOL reagent (Invitrogen) following the manufacturer's protocol. cDNA was prepared using High Capacity cDNA Reverse Transcription kit (Applied Biosystems) and quantitative RT-PCR was performed using the Light Cycler 480 SYBR Green I Master mix (Roche Diagnostics) on a LightCycler 480 II machine (Roche Diagnostics). Expression levels were measured by using the following primers: Cxcl13, QT00107919, Ccl21a, QT00284753, Ccl21b, QT00314097, S1pr1, QT00243628, S1pr2 QT00262773 (QuantiTect primer assay; QIAGEN), Ccl19, forward: 5 0 -CTG CCT CAG ATT ATC TGC CAT-3 0 , reverse: 5 0 -AGG TAG CGG AAG GCT TTC AC-3 0 , tbp: forward: 5 0 -CCT TCA CCA ATG ACT CCT ATG AC-3 0 , reverse: 5 0 -CAA GTT TAC AGC CAA GAT TCA C-3 0 .
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical details for all experiments can be found in the according figure legends. Statistical analyses were performed with Prism 5.0 (GraphPad software). Data were analyzed with the non-paired Student's t test or one-way-ANOVA (including the Bonferroni multiple comparisons test). A p value of < 0.05 was considered as significant (*p < 0.05, **p < 0.01, ***p < 0.001).
